Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Sudden cardiac death; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number SI-JAZMP-NCPHV-2021SI0371_0371. A 78-year-old male patient received the second dose of BNT162B2 (COMIRNATY; lot number: ET3620, expiry date: 30Jun2021), intramuscular on 17Mar2021 at single dose for COVID-19 immunisation. The patient''s medical history included type II diabetes mellitus with vascular complications, atherosclerosis generalized, acute myocardial infarction (condition after acute myocardial infarction). The patient''s concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (COMIRNATY) on an unspecified date for COVID-19 immunization. On 25Mar2021, the patient experienced sudden cardiac death. The outcome of the event was fatal. It was not reported if an autopsy was performed. This case report was assessed as medically significant. No additional data arrived in the initial case report. Sender Comment: Further data on the case along with the assessment is expected. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Sudden cardiac death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166